{"id":"NCT01355081","sponsor":"Takeda","briefTitle":"Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase III Study to Assess the Efficacy and Safety of Lu AA21004 in Patients With Major Depressive Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-05","primaryCompletion":"2012-12","completion":"2012-12","firstPosted":"2011-05-17","resultsPosted":"2014-11-11","lastUpdate":"2014-11-11"},"enrollment":366,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"Vortioxetine","otherNames":["Lu AA21004","BRINTELLIX"]},{"type":"DRUG","name":"Placebo","otherNames":["Vortioxetine placebo-matching tablets"]}],"arms":[{"label":"Vortioxetine 5 mg","type":"EXPERIMENTAL"},{"label":"Vortioxetine 10 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the efficacy, safety and tolerability of 8-week treatment with Vortioxetine (Lu AA21004), once daily (QD), in Japanese participants with major depressive disorder.\n\nThe purpose of this study is to assess the efficacy, safety and tolerability of 8-week treatment with Lu AA21004, once daily (QD), in Japanese participants with major depressive disorder.","primaryOutcome":{"measure":"Change From Baseline in Montgomery-Ã…sberg Depression Rating Scale (MADRS) Total Score After 8 Weeks of Treatment","timeFrame":"Baseline, Week 8","effectByArm":[{"arm":"Vortioxetine 5 mg","deltaMin":-15.84,"sd":0.885},{"arm":"Vortioxetine 10 mg","deltaMin":-14.85,"sd":0.874},{"arm":"Placebo","deltaMin":-13.81,"sd":0.87}],"pValues":[{"comp":"OG000 vs OG002","p":"0.1031"},{"comp":"OG001 vs OG002","p":"0.4008"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":32,"countries":["Japan"]},"refs":{"pmids":["29160598"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":119},"commonTop":["Nausea","Nasopharyngitis","Diarrhoea","Somnolence","Headache"]}}